Ethics Involving Human Subject Research in Military Medicine

군진의학 연구에서 인간대상 연구윤리

  • Kwon, Ivo (Department of Medical Education, School of Medicine, Ewha Womans University)
  • 권복규 (이화여자대학교 의과대학 의학교육학교실)
  • Received : 2022.09.01
  • Accepted : 2022.09.25
  • Published : 2022.09.30

Abstract

The goal of the military medicine is not as same as that of the civil medical practice, and consequently the characteristics of military biomedical researches have their own uniqueness. In front of the prerogative of national defense, some of the human rights ordinarily ensured in normal researches with human subjects are not to be fully guaranteed. The hierarchic system of the military would complicate the issue when the soldiers are enrolled as human subject for the research. Some researches could be classified as a military secret, therefore, the confidentiality issues need to be well addressed. Institutional Review Board and review procedure should be modified for the military purposes. So, it is necessary to establish the appropriate regulatory system for the military biomedical researches with human subject to manage the complicated issues involved in them.

Keywords

References

  1. Kim BJ. Human right accountability of PSCMC and the role of international control. Jus-Gentium 2014;13:69-81.
  2. Frisina M. Medical ethics in military biomedical research. In: Beam TE, Sparacino LR, Pellegrino ED, Hartle AE, Howe EG, editors. Military medical ethics. Volume 2. Washington, DC: TMM Publications, Borden Institute, Walter Reed Army Medical Center; 2003. p. 533-61.
  3. Park SM, Park KT, Choi BI. The operation of Institutional Review Boards in Korean Military Research Institutions and the protection program for active-duty military research participants. Pers Bioeth 2020;10:39-70.
  4. Zaninelli M, Paarlberg R. Clinical trial disclosure and data transparency: obligation or opportunity? [Internet]. Applied Clinical Trial; 2021 [cited 2021 Jul 10]. Available from: https://www.appliedclinicaltrialsonline.com/view/clinical-trial-disclosure-and-data-transparency-obligationor-opportunity-.
  5. Moorthy VS, Karam G, Vannice KS, Kieny MP. Rationale for WHO's new position calling for prompt reporting and public disclosure of interventional clinical trial results. PLoS Med 2015;12: e1001819. https://doi.org/10.1371/journal.pmed.1001819
  6. Resnik DB. Openness versus secrecy in scientific research. Episteme 2006;2:135-47. https://doi.org/10.3366/epi.2005.2.3.135
  7. Normile D. Aftermath. Science 2020;369:361-5. https://doi.org/10.1126/science.369.6502.361
  8. Lee JT. Will the Armed Forces Capital Hospital be able to conduct its own clinical trials for soldiers? K-Pharm News [Internet]. July 10, 2021 [cited 2021 Jul 10]. Available from: https://www.kpanews.co.kr/article/show.asp?idx=224013.
  9. Definition of terminology in Guideline for Korean Good Clinical Practice [Internet]. Sejong (Korea): Korean Law Information Center; 2020 [cited 2019 Dec 6]. Available from: https://www.law.go.kr/LSW/lsBylInfoP.do?bylSeq=10297391&lsiSeq=220711.
  10. Ministry of Food and Drug Safety. Considerations for clinical trials related to COVID-19 Notice [Internet]. Cheongju (Korea): Ministry of Food and Drug Safety; 2021 [cited 2021 Jan 12]. Available from: https://nedrug.mfds.go.kr/bbs/38/111.